Eudaimonia Partners’s CapForce IBD Breakout Opportunities ETF BOUT Stock Holding History

Eudaimonia Partners’s Portfolio BOUT Stock Details BOUT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-962	Closed	-$32K	–	497
2021 Q1	$32K	Sell	962 -427	-31%	-$14.7K	0.01%	782
2020 Q4	$44K	Buy	1,389 +170	+14%	+$4.65K	0.01%	641
2020 Q3	$29K	Sell	1,219 -159	-12%	-$3.74K	0.01%	697
2020 Q2	$31K	Sell	1,378 -61	-4%	-$1.26K	0.01%	609
2020 Q1	$26K	Sell	1,439 -1,530	-52%	-$30.8K	0.01%	597
2019 Q4	$62K	Buy	+2,969	New	+$58.9K	0.02%	443

Other funds holding BOUT

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Flow Traders U.S. New York $2.43B AUM 44.44% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

APA

American Portfolios Advisors Holbrook, New York $2.36B AUM 14.59% 1-Year Est. Return

Patriot Financial Group Insurance Agency Westborough, Massachusetts $1.05B AUM 21.28% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Asset Dedication LLC San Francisco, California $1.59B AUM 26.56% 1-Year Est. Return

Benjamin F. Edwards & Company St. Louis, Missouri $5.69B AUM 15.37% 1-Year Est. Return

Eudaimonia Partners's BOUT Position: Q2 2021 in Review

Eudaimonia Partners sold out of CapForce IBD Breakout Opportunities ETF (BOUT) in Q2 2021, closing a stake of 962 shares — an estimated $32K sold.

Eudaimonia Partners first reported a position in BOUT in Q4 2019 and held it in 6 quarters. The position peaked at $62K in Q4 2019. 11 funds tracked by Wall St. Rank hold BOUT as of Q2 2021.

Eudaimonia Partners reported no remaining CapForce IBD Breakout Opportunities ETF position as of Q2 2021 after selling out during the quarter.
Eudaimonia Partners sold 962 CapForce IBD Breakout Opportunities ETF shares in Q2 2021, an estimated $32K.
Eudaimonia Partners first reported a position in CapForce IBD Breakout Opportunities ETF in Q4 2019 and held it in 6 quarters.
Eudaimonia Partners's CapForce IBD Breakout Opportunities ETF position peaked at $62K in Q4 2019.
11 funds tracked by Wall St. Rank held CapForce IBD Breakout Opportunities ETF as of Q2 2021.

Based on Eudaimonia Partners's 13F filing for Q2 2021, filed 13 Aug 2021.